Luisa CorreiaAna Correia Lab of Cancer Dormancy & ImmunityPortugal

Ana Luisa Correia received her B.Sc. in Applied Biology from the University of Minho, Portugal. As a student of the GABBA program, she pursued her PhD studies on the role of the microenvironment in breast cell invasion at the Lawrence Berkeley Lab, USA, and then a postdoc at the FMI and the University of Basel, Switzerland, exploring tissue-specific mechanisms controlling breast cancer progression. Ana is currently a Principal Investigator at the Champalimaud Foundation, where she leads the Cancer Dormancy & Immunity Lab. The goal of her research is to understand how disseminated tumor cells interact with the unique microenvironment in each distant site, and leverage this knowledge into more effective therapeutic interventions for patients risking metastases. Ana has received a few international awards (2021 Metastasis Research Prize, 2022 Pfizer Oncology, AACR 2022 NextGen Stars), is an EMBO Young Investigator, and serves as an active member at the EACR, AACR and MRS societies.